April 19, 2024

Astrana Health (NASDAQ:ASTH – Get Free Report) is one of 67 publicly-traded companies in the “Management consulting services” industry, but how does it compare to its competitors? We will compare Astrana Health to similar businesses based on the strength of its earnings, analyst recommendations, institutional ownership, valuation, risk, dividends and profitability.

Valuation & Earnings

This table compares Astrana Health and its competitors revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Astrana Health $1.39 billion $60.72 million 30.05
Astrana Health Competitors $1.64 billion $115.72 million 10.71

Astrana Health’s competitors have higher revenue and earnings than Astrana Health. Astrana Health is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Risk and Volatility

Astrana Health has a beta of 1.1, indicating that its stock price is 10% more volatile than the S&P 500. Comparatively, Astrana Health’s competitors have a beta of 0.99, indicating that their average stock price is 1% less volatile than the S&P 500.

Institutional and Insider Ownership

35.9% of Astrana Health shares are owned by institutional investors. Comparatively, 40.5% of shares of all “Management consulting services” companies are owned by institutional investors. 8.5% of Astrana Health shares are owned by company insiders. Comparatively, 28.1% of shares of all “Management consulting services” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of current ratings for Astrana Health and its competitors, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Astrana Health 0 1 1 0 2.50
Astrana Health Competitors 69 571 1438 58 2.70

Astrana Health presently has a consensus price target of $47.00, suggesting a potential upside of 18.48%. As a group, “Management consulting services” companies have a potential upside of 19.53%. Given Astrana Health’s competitors stronger consensus rating and higher possible upside, analysts plainly believe Astrana Health has less favorable growth aspects than its competitors.


This table compares Astrana Health and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Astrana Health 4.49% 11.52% 6.67%
Astrana Health Competitors -66.26% -359.58% -19.21%


Astrana Health competitors beat Astrana Health on 8 of the 13 factors compared.

About Astrana Health

(Get Free Report)

Apollo Medical Holdings, Inc. engages in the provision of healthcare services. It offers integrated care, inpatient and physician alignment solutions. The company focuses on physicians providing high-quality medical care, population health management and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Apollo Medical Holdings, Inc. is headquartered in Glendale, CA.

Receive News & Ratings for Astrana Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Astrana Health and related companies with MarketBeat.com’s FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *